about
Identification of unique microRNA signature associated with lupus nephritisCurrent and emerging treatment options in the management of lupusKey issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implicationsBelimumab in systemic lupus erythematosus: a perspective reviewNon-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosusJuvenile systemic lupus erythematosus: review of clinical features and managementTargeting dendritic cell function during systemic autoimmunity to restore toleranceContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosusA phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusPatients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapyPediatric lupus nephritis: Management updateBelimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysisRisk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse Events.Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case reportSafety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.Missed opportunities for timely diagnosis of pediatric lupus in South Africa: a qualitative study.Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.A national study of the complications of lupus in pregnancy.Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population.Systemic lupus erythematosus with a non functioning pituitary macroadenoma.Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.Disease flare patterns and predictors of systemic lupus erythematosus in a monocentric cohort of 423 Japanese patients during a long-term follow-up: The JUDE study.Defining Low Disease Activity in Systemic Lupus Erythematosus.Active haematological manifestations of systemic lupus erythematosus lupus are associated with a high rate of in-hospital mortality.Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX)Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study.The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus.Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus PatientsPediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Management of cardiovascular complications in systemic lupus erythematosus.Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort.Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.
P2860
Q21136392-1BCC641D-6110-4D78-814C-2FEF3ED8299EQ26741266-5EA5B827-90CA-43A4-BB95-22F58BB10C3DQ26775756-F3A6D85A-0664-425F-942A-E941585F35AFQ26796486-9AB99630-1376-476B-9F7A-1D239B816697Q26796871-09FA1751-7408-4EEE-94DF-18F246807213Q26849746-C1CA3631-A1AE-4FE2-ADC5-6E7BA1398083Q27687098-2C00DCFE-7FD0-4706-9FCD-5583B4A1A140Q28080920-C86CBEE3-C778-4E05-9C58-3008714E7AE5Q28254310-12FD0297-19A5-42CE-AE62-5B52F84F648BQ28651110-3C237D7C-C429-4D42-A2AE-7C60AF4BDD2FQ28660110-CDDBE924-3E6F-4278-B6E6-7309476D5636Q28676968-D8B88FAD-5621-4BFF-9ECB-517820E371A0Q30245390-E3773EEA-AB90-4937-9CDF-C1C84BC1386DQ30248866-617E5569-3C68-4805-891A-3129117A83D5Q30405609-0DABFDB0-C24E-4817-B280-707892563ED4Q30411157-88E7DEF6-C833-4205-8CB6-B8ACBED10D75Q30580226-E1F47137-A4DE-4BF8-818C-CC504F35036FQ30582614-74B2A0F9-AE46-4AB2-BBF0-975F2FBF3733Q30839806-9BFF77BF-FB2B-45D5-AB4E-22CD9C01F1E8Q31102783-B35E2F3B-413C-4C0C-8BBE-4AE5F4308A5DQ33377578-78EF0A3D-02B7-491A-8948-50E7DC2C0746Q33379485-084DEE90-68D9-46AF-81A8-26A6E2FE6176Q33387473-CE46D45D-6319-45B4-B2D2-28EEC2C31AAEQ33392397-05BB4E1A-0874-4109-95AB-240D5FFA1DDAQ33406968-CCD4D342-DD24-4F61-805D-F73D1E98BAA2Q33414595-3B213858-E62F-4772-B563-EC2C1992BC78Q33434719-8507C471-ECD0-4DEC-816B-F90592564BEBQ33435736-B0CFB4E3-87C3-4136-AC95-D7FB350A131DQ33436146-B6E1F2BA-530B-4C1F-BD7B-738306A956F4Q33448450-769B765F-600D-44B6-8DB8-A839A74DE3E1Q33455990-B48D8746-7A69-4B4E-9ED4-9BE84CA5BBA7Q33511924-CE6130FD-1909-450D-8813-B25228190ECBQ33570432-BB815584-AED8-45E9-8C37-67234F4852EAQ33576353-F7929106-7BEA-4042-9D37-9AB5D83BF303Q33584053-12C2B5A1-B7B5-421F-93F9-C11F283E7330Q33662822-8B0EACB9-8124-4CE4-88D4-34210F4BD341Q33723511-77AD170E-D0EF-42ED-93BF-91435A2A5FCCQ33730536-7D72B711-B348-4C1F-B35C-FB0F1AA09DB5Q33758208-8129FE1A-264E-4E1F-99DD-0E78E38BB9E7Q33766242-D3EE8631-8B45-4D65-9531-8FDD2C748B6A
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mortality in systemic lupus erythematosus.
@en
type
label
Mortality in systemic lupus erythematosus.
@en
prefLabel
Mortality in systemic lupus erythematosus.
@en
P2093
P50
P356
P1476
Mortality in systemic lupus erythematosus.
@en
P2093
G Sturfelt
H El-Gabalawy
P304
P356
10.1002/ART.21955
P577
2006-08-01T00:00:00Z